scGRNom: a computational pipeline of integrative multi-omics analyses for predicting cell-type disease genes and regulatory networks

T Jin, P Rehani, M Ying, J Huang, S Liu, P Roussos… - Genome Medicine, 2021 - Springer
Understanding cell-type-specific gene regulatory mechanisms from genetic variants to
diseases remains challenging. To address this, we developed a computational pipeline …

Future therapeutics in Alzheimer's disease: development status of BACE inhibitors

G Evin - BioDrugs, 2016 - Springer
Alzheimer's disease (AD) is the primary cause of dementia in the elderly. It remains
incurable and poses a huge socio-economic challenge for developed countries with an …

[HTML][HTML] Alzheimer's disease: Amyloid-based pathogenesis and potential therapies

Y Zhou, Y Sun, QH Ma, Y Liu - Cell stress, 2018 - ncbi.nlm.nih.gov
Alzheimer's disease is one of the most severe neurodegenerative diseases among elderly
people. Different pathogenic factors for Alzheimer's disease have been posited and studied …

The vexing complexity of the amyloidogenic pathway

MA Castro, A Hadziselimovic, CR Sanders - Protein Science, 2019 - Wiley Online Library
The role of the amyloidogenic pathway in the etiology of Alzheimer's disease (AD),
particularly the common sporadic late onset forms of the disease, is controversial. To some …

Brain region-specific differences in amyloid-β plaque composition in 5XFAD mice

AS Bader, MU Gnädig, M Fricke, L Büschgens… - Life, 2023 - mdpi.com
Senile plaques consisting of amyloid-beta (Aβ) peptides are a major pathological hallmark
of Alzheimer's disease (AD). Aβ peptides are heterogeneous regarding the exact length of …

[HTML][HTML] A rare missense variant of CASP7 is associated with familial late-onset Alzheimer's disease

X Zhang, C Zhu, G Beecham, BN Vardarajan, Y Ma… - Alzheimer's & …, 2019 - Elsevier
Introduction The genetic architecture of Alzheimer's disease (AD) is only partially
understood. Methods We conducted an association study for AD using whole sequence data …

Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease

C Zou, E Montagna, Y Shi, F Peters… - Acta …, 2015 - Springer
Alzheimer's disease (AD) is thought to be caused by accumulation of amyloid-β protein (Aβ),
which is a cleavage product of amyloid precursor protein (APP). Transgenic mice …

Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease

F Aichholzer, HW Klafki, I Ogorek, J Vogelgsang… - Alzheimer's research & …, 2021 - Springer
Background Alzheimer's disease (AD) is a neurodegenerative disorder associated with
extracellular amyloid-β peptide deposition and progressive neuron loss. Strong evidence …

Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein

G Kaur, M Pawlik, SE Gandy, ME Ehrlich… - Molecular …, 2017 - nature.com
Recent data suggest that intraneuronal accumulation of metabolites of the amyloid-β-
precursor protein (APP) is neurotoxic. We observed that transgenic mice overexpressing in …

Cyclin dependent kinase 5: A novel avenue for Alzheimer's disease

AS Bhounsule, LK Bhatt, KS Prabhavalkar, M Oza - Brain research bulletin, 2017 - Elsevier
Alzheimer's disease (AD) is one of the most frequently encountered diseases in adults with
progressive loss of memory and behavioral changes. Inspite of there being an intense …